Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ADH1B | P00325 | 2/20 | 0.41 |
| ▸ | ADH1C | P00326 | 2/20 | 0.41 |
| ▸ | ADH1A | P07327 | 2/20 | 0.41 |
| ▸ | ADH4 | P08319 | 2/20 | 0.41 |
| ▸ | ADH7 | P40394 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27493775 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL19963745 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL7775120 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL27371938 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL25122655 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL24508589 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL19205925 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL7777007 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL21808586 | 1.00 | EPHX1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B | |
| SCHEMBL24596012 | 0.97 | ALDH1A1 (0.46) | EPHX1KDM4EALDH1A1TSHRADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4107198-B1 | POLYISOCYANATE PREPARATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2024-03-13 | — | — | EP | disclosed |
| EP-3560975-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES AND ANTIOXIDANTS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-12-06 | — | — | EP | disclosed |
| EP-3724251-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-11-22 | — | — | EP | disclosed |
| EP-3851472-B1 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-06-07 | — | — | EP | disclosed |
| EP-4107198-A1 | POLYISOCYANATE PREPARATIONS | Covestro Deutschland AG (DE) | 2022-12-28 | — | — | EP | disclosed |
| CN-108602955-B | Photocuring method, compound used in photocuring method, and composition | 富士胶片和光纯药株式会社 | 2021-08-06 | — | — | CN | disclosed |
| US-10847594-B2 | Organic light emitting display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-11-24 | — | — | US | disclosed |
| CN-110678500-A | Photo-or thermosetting method and curable resin composition | 富士胶片和光纯药株式会社 | 2020-01-10 | — | — | CN | disclosed |
| US-10278839-B2 | Endovascular impant | INTACT VASCULAR, INC. (US) | 2019-05-07 | — | — | US | disclosed |
| CN-108602955-A | The compound and composition used in process for photocuring, the process for photocuring | 富士胶片和光纯药株式会社 | 2018-09-28 | — | — | CN | disclosed |
| US-7291212-B2 | Ink and ink set for ink jet printing and method of ink jet printing | FUJIFILM CORPORATION (JP) | 2007-11-06 | — | — | US | disclosed |
| CN-1254232-C | Topical compositions containing fluid-absorbent solids and adhesive fluids | PROCTER & GAMBLE (US) | 2006-05-03 | — | — | CN | disclosed |
| CN-1558750-A | Topical compositions containing fluid-absorbent solids and adhesive fluids | — | 2004-12-29 | — | — | CN | disclosed |
| CN-1130351-C | 1,5-benzodiazepine derivatives | ZERIA PHARM CO LTD (JP) | 2003-12-10 | — | — | CN | disclosed |
| CN-1084739-C | Process for producing 2-hydroxybenzamide derivatives | ZERIA PHARMACEUTICAL CO.,LTD. (JP) | 2002-05-15 | — | — | CN | disclosed |
| EP-0838508-B1 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORP (JP) | 2001-08-29 | — | — | EP | disclosed |
| CN-1261357-A | Process for preparing 2-hydroxybenzamide derivatives | ZERIA PHARM CO LTD (JP) | 2000-07-26 | — | — | CN | disclosed |
| CN-1246850-A | 1,5-benzodiazepine derivatives | ZERIA PHARM CO LTD (JP) | 2000-03-08 | — | — | CN | disclosed |
| US-5871572-A | COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID | SEIKO EPSON CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0838508-A2 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORPORATION (JP) | 1998-04-29 | — | — | EP | disclosed |